stoxline Quote Chart Rank Option Currency Glossary
TherapeuticsMD, Inc. (TXMD)
2.8511  0.061 (2.19%)    11-28 13:34
Open: 2.8
High: 2.92
Volume: 8,599
Pre. Close: 2.79
Low: 2.8
Market Cap: 30(M)
Technical analysis
2023-11-28 1:50:57 PM
Short term     
Mid term     
Targets 6-month :  3.58 1-year :  4.18
Resists First :  3.06 Second :  3.58
Pivot price 2.44
Supports First :  2.37 Second :  1.95
MAs MA(5) :  2.83 MA(20) :  2.38
MA(100) :  3.21 MA(250) :  4.03
MACD MACD :  0.1 Signal :  0
%K %D K(14,3) :  81.3 D(3) :  79.8
RSI RSI(14): 60.7
52-week High :  7.17 Low :  1.95
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ TXMD ] has closed below upper band by 21.4%. Bollinger Bands are 126.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 5 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.88 - 2.9 2.9 - 2.91
Low: 2.75 - 2.77 2.77 - 2.78
Close: 2.76 - 2.79 2.79 - 2.81
Company Description

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Headline News

Fri, 24 Nov 2023
Bio-Identical Hormone Replacement Market To Reach USD 61.5 ... - GlobeNewswire

Wed, 22 Nov 2023
TherapeuticsMD Inc. stock outperforms competitors despite losses on the day - MarketWatch

Fri, 17 Nov 2023
TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch

Wed, 15 Nov 2023
TherapeuticsMD: Q3 Earnings Snapshot - The Washington Post - The Washington Post

Mon, 30 Oct 2023
TherapeuticsMD Inc (TXMD) Stock: Do Analysts Think You Should Hold? - InvestorsObserver

Thu, 26 Oct 2023
TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Drug Manufacturers—Specialty & Generic
Shares Out 0 (M)
Shares Float 11 (M)
Held by Insiders 7.08e+006 (%)
Held by Institutions 8.1 (%)
Shares Short 104 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 5.16e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 98.4 %
Operating Margin 3 %
Return on Assets (ttm) 345.2 %
Return on Equity (ttm) 34.5 %
Qtrly Rev. Growth 6.937e+007 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 4.8 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -141 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 1.24
Stock Dividends
Dividend 0
Forward Dividend 248470
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android